Comparison of Two Different Drug Regimens for Medical Treatment of Early Pregnancy Loss
Status:
Recruiting
Trial end date:
2023-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the safety and efficacy of a combination of two drugs
(mifepristone and misoprostol) to only one of these drugs (misoprostol) in medical management
of missed miscarriage up to 13+6 weeks of pregnancy (early pregnancy loss).
The investigators aim to enroll 220 patients within two years which would be enough to
determine the difference between these two treatments with confidence.